| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 05/03/2007 | WO2007049359A1 Method of controlling glucose metabolism |
| 05/03/2007 | WO2007049043A2 Tnf alpha ngf molecular switch for determining cell fate |
| 05/03/2007 | WO2007048811A1 Pharmaceutical compositions comprising tricalcium phosphate and calcium carbonate |
| 05/03/2007 | WO2007028821A3 Treatment of autoimmune diseases |
| 05/03/2007 | WO2007028645A3 Antimicrobial medical product method for production and use thereof |
| 05/03/2007 | WO2007026219A3 Combinations of a 5-ht1b antagonist with a noradrenalin re-uptake inhibitor or a serotonin noradrenalin reutake inhibitor for treating cns conditions |
| 05/03/2007 | WO2007009462A3 Treatment of migraine and headaches |
| 05/03/2007 | WO2006123358A3 Stabilized atorvastatin-containing formulation |
| 05/03/2007 | WO2006121362A3 Use of antagonists of oxytocin and/or vasopressin in assisted reproduction |
| 05/03/2007 | WO2006108667A3 Method of treatment using gh antagonist and somatostatin agonist |
| 05/03/2007 | WO2006094924A3 New pharmaceutical compositions based on anticholinergics and pde 5-inhibitors |
| 05/03/2007 | WO2005079514A3 Preservation of blood vessels for grafting using inhibitors of tnf-alpha |
| 05/03/2007 | WO2005011602A3 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a pde-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease |
| 05/03/2007 | WO2004093811A3 Compositions of a cyclooxygenase-2 selective inhibitor and a sodium ion channel blocker for the treatment of central nervous system damage |
| 05/03/2007 | WO2002081649A3 ErbB INTERFACE PEPTIDOMIMETICS AND METHODS OF USE THEREOF |
| 05/03/2007 | US20070101451 LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies |
| 05/03/2007 | US20070100561 Crystals of DPP-IV |
| 05/03/2007 | US20070100001 Use of R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereof |
| 05/03/2007 | US20070099996 Pharmaceutical compositions of acitretin |
| 05/03/2007 | US20070099932 External preparation for athlete's foot treatment |
| 05/03/2007 | US20070099907 Use of meloxicam in combination with an antiplatelet agent for treatment of acute coronary syndrome and related conditions |
| 05/03/2007 | US20070099906 Combinations for the treatment of noeplastic disorders |
| 05/03/2007 | US20070099905 Combinations of drugs for the treatment of neoplasms |
| 05/03/2007 | US20070099904 Pharmaceutical composition for the treatment of cns and other disorders |
| 05/03/2007 | US20070099899 Heterocyclic dihydropyrimidine compounds |
| 05/03/2007 | US20070099891 Medicinal compositions and combinations |
| 05/03/2007 | US20070099864 Use of o-atp for the treatment of diseases involving angiogenesis |
| 05/03/2007 | US20070099855 Glycyrrhizin or derivatives thereof for for treating or preventing severe acute respiratory syndrome (sars) |
| 05/03/2007 | US20070099849 Co-Therapy for the Treatment of Migraine Comprising Anticonvulsant Derivatives and Anti-Migraine Agents |
| 05/03/2007 | US20070099846 Administering or applying anserine for treating muscle spasm, localized swelling, inflammation, joint pains, muscle fatigue, stress and myocardial infarction optionally with a diuretic |
| 05/03/2007 | US20070099844 Novel methods for the treatment of cancer |
| 05/03/2007 | US20070099836 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment |
| 05/03/2007 | US20070099822 Regulation of tissue mineralization and phosphate metabolism by asarm peptides |
| 05/03/2007 | US20070099175 Modified fluorescent proteins |
| 05/03/2007 | US20070098816 Pharmaceutical composition containing histone deacetylase inhibitor |
| 05/03/2007 | US20070098800 Therapeutic compositions |
| 05/03/2007 | US20070098775 Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels |
| 05/03/2007 | US20070098741 Vectors derived from antibodies for transferring substances into cells |
| 05/03/2007 | US20070098736 Injection vehicle for polymer-based formulations |
| 05/03/2007 | US20070098724 Methods of Treatment Using Vascular Occlusion in Combination with One or More Therapies |
| 05/03/2007 | US20070098677 Ophthalmic compositions containing galactomannan polymers and borate |
| 05/03/2007 | US20070098634 method of inhibiting the growth; inhibiting neoplastic cell growth; cancer |
| 05/03/2007 | DE19940220B4 Medizinisches Präparat zur Behandlung von Arthrose, Arthritis und anderen rheumatischen Gelenkerkrankungen A medical preparation for the treatment of osteoarthritis, arthritis and other rheumatic joint diseases |
| 05/03/2007 | DE112005000725T5 Verfahren und Zusammensetzungen zur Behandlung von Ionen-Ungleichgewichten Methods and compositions for treatment of ion imbalance |
| 05/03/2007 | DE10158036B4 Antiallergisches Mittel und dessen Verwendung Anti-allergic agent and its use |
| 05/03/2007 | CA2627463A1 Anti mineralocorticoid therapy of infection |
| 05/03/2007 | CA2626879A1 Method for predicting efficacy of rar-.alpha. agonist |
| 05/03/2007 | CA2624221A1 Preventives/remedies for cancer |
| 05/02/2007 | EP1780278A2 Mammalian calcium channels and related probes, cell lines and methods |
| 05/02/2007 | EP1780276A1 Bone/joint disease sensitivity gene and use thereof |
| 05/02/2007 | EP1780268A2 PSCA: Prostate stem cell antigen and uses thereof |
| 05/02/2007 | EP1779867A1 Nerve reveneration promoter |
| 05/02/2007 | EP1779851A1 Treatment of diabetes |
| 05/02/2007 | EP1778287A2 Combination therapy with nk3 receptor antagonists for the treatment of schizophrenia |
| 05/02/2007 | EP1778285A2 Treatment of ccr2 mediated diseases or disorders |
| 05/02/2007 | EP1778275A2 Combination therapy for diabetes, obesity, and cardiovascular diseases using gdf-8 inhibitors |
| 05/02/2007 | EP1778267A2 Compositions and methods related to heart failure |
| 05/02/2007 | EP1778256A1 Use of xenon as neuroprotectant in a neonatal subject |
| 05/02/2007 | EP1778211A1 Methods and materials for treating mental illness |
| 05/02/2007 | EP1778207A2 Combination compositions comprising 13-cis-retinyl derivatives and uses thereof to treat opthalmic disorders |
| 05/02/2007 | EP1635838B1 Phosphodiesterase-5-inhibitors for the prophylaxis and/or treatment of portal hypertension |
| 05/02/2007 | EP1526870B1 Combination of loteprednoletabonat and dfho for treating respiratory diseases, allergic diseases, asthma and copd |
| 05/02/2007 | EP1501517B1 Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for the long-term prevention of acute urinary retention |
| 05/02/2007 | EP1471871B1 Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin |
| 05/02/2007 | EP1441723B1 Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension |
| 05/02/2007 | EP1346058B1 Adenoviral systems and the uses thereof |
| 05/02/2007 | EP1330537B1 Membrane fractions of cells enriched in 1,2-sn-diacylglycerol |
| 05/02/2007 | EP1282725B1 METHODS OF MODULATING FUNCTIONS OF POLYPEPTIDE GalNAc TRANSFERASES AND OF SCREENING SUBSTANCES THEREFOR |
| 05/02/2007 | EP1280826B1 Polypeptides for inhibiting april-mediated b- and t-cell proliferation. |
| 05/02/2007 | EP1261372B1 Method of treating cancer with anti-neurotrophin agents |
| 05/02/2007 | EP1220830B1 Use of elastase for opening obstructed arteries and veins |
| 05/02/2007 | EP1100921B1 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 05/02/2007 | EP1077069B1 Preventives/remedies for hepatic cirrhosis |
| 05/02/2007 | EP1032405A4 Antimutagenic compositions for treatment and prevention of photodamage to skin |
| 05/02/2007 | EP0998305B1 Cytolysis of target cells by superantigen conjugates inducing t-cell activation |
| 05/02/2007 | EP0946183B1 Use of pyridazinone or phosphine oxide compounds to treat or prevent cardiac arrhythmia |
| 05/02/2007 | EP0912085B1 Precise efficacy assay methods for active agents including chemotherapeutic agents |
| 05/02/2007 | CN1956979A Thiazole derivative |
| 05/02/2007 | CN1956732A Antimycobacterial pharmaceutical composition comprising an antitubercular drug |
| 05/02/2007 | CN1956726A Composition and method for releasing mammal inflammation and oxidation stress |
| 05/02/2007 | CN1956720A Combination medication for treating HIV infection |
| 05/02/2007 | CN1956716A Medicine capable of inhibiting activation of transcription factor KLF5 |
| 05/02/2007 | CN1955280A Potency regeneration cell and culturing method thereof |
| 05/02/2007 | CN1954826A Use of ginkgo biloba extract in cholesterol reducing |
| 05/02/2007 | CN1313441C Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents |
| 05/02/2007 | CN1313155C Topical composition comprising a cyclofructan, a carrier and a drug |
| 05/02/2007 | CN1313150C Therapeutic agent for treating autoimmune diseases |
| 05/02/2007 | CN1313147C Treatment of inner ear hair cells |
| 05/02/2007 | CN1313146C Methods and compositions useful for inhibition of 'alpha'v'beta'5 mediated angiogenesis |
| 05/02/2007 | CN1313099C Carbon gas gel transfusion agent, its preparing method and its use |
| 05/02/2007 | CN1313089C Stimulation of CPT-1 as a means to reduce weight |
| 05/02/2007 | CN1313084C Percutaneous contraceptive drugs delivery system and preparing method |
| 05/02/2007 | CN1313069C Composition for hair and/or scalp |
| 05/01/2007 | US7211694 Substituted 4-aminocyclohexanols |
| 05/01/2007 | US7211602 Treatment of neurodegenerative disorders through the modulation of the polyamine pathway |
| 05/01/2007 | US7211598 Oxime and/or hydrozone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 05/01/2007 | US7211590 Such as 2-(nitrooxy)ethyl-2-(((3-methyl-4-(2,2,2-trifluoro-ethoxy)-2 -pyridyl)methyl)sulfinyl)benzimidazolecarboxylate; kits; for treating gastrointestinal disorders/ulcers |
| 05/01/2007 | US7211582 Effective, non-sedating antihistamine for treating allergic rhinitis; avoiding adverse side-effects |
| 05/01/2007 | US7211570 Administering 5-substituted uracil-nucleosides or its pharmaceutically acceptable salt or prodrug for therapy of infected with Epstein-Barr virus or Kaposi's sarcoma-associated herpes ("KHSV") |
| 05/01/2007 | US7211563 For use in diagnosis, study, prophylaxis, and therapy of diseases and disorders related to body-weight regulation, metabolic diseases such as obesity, as well as related disorders such as adipositas, eating disorders, cachexia |